Mytrex Health Technologies (ROCO:4431) Beginning Cash Position: NT$301 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4431 Mytrex Health Technologies Inc ROCO:4431
71 GF Score
Price NT$19.55
GF Value NT$28.73
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Mytrex Health Technologies Beginning Cash Position?

Mytrex Health Technologies ROCO:4431 +0.26% 71 Beginning Cash Position is NT$301 Mil as of Jun. 2026. GuruFocus rates ROCO:4431 with a GF Score™ of 71/100 and a GF Value™ of NT$28.73 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Mytrex Health Technologies's Beginning Cash Position for the quarter that ended in Jun. 2026 was NT$301 Mil.

Mytrex Health Technologies's quarterly Beginning Cash Position declined from Jun. 2025 (NT$275 Mil) to Dec. 2025 (NT$187 Mil) but then increased from Dec. 2025 (NT$187 Mil) to Jun. 2026 (NT$301 Mil).

Mytrex Health Technologies's annual Beginning Cash Position declined from Dec. 2023 (NT$487 Mil) to Dec. 2024 (NT$219 Mil) but then increased from Dec. 2024 (NT$219 Mil) to Dec. 2025 (NT$275 Mil).

Mytrex Health Technologies Beginning Cash Position Related Terms

Mytrex Health Technologies Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Mytrex Health Technologies's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mytrex Health Technologies Beginning Cash Position Chart

Mytrex Health Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 735.29 559.73 486.53 218.66 275.02

Mytrex Health Technologies Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 218.66 303.46 275.02 187.48 300.63
ROCO:4431
71GF Score
Mytrex Health Technologies Inc ROCO:4431
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mytrex Health Technologies Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of NT$301 Mil mean?
Mytrex Health Technologies (ROCO:4431) has a Beginning Cash Position of NT$301 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Mytrex Health Technologies and its competitors.
Is Mytrex Health Technologies' Beginning Cash Position too high?
Mytrex Health Technologies' current Beginning Cash Position is NT$301 Mil. Overall, Mytrex Health Technologies has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mytrex Health Technologies' Beginning Cash Position compare to GEV and ETN?
Mytrex Health Technologies' Beginning Cash Position of NT$301 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for an Industrial Products company?
A good Beginning Cash Position depends on the Industrial Products industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Mytrex Health Technologies and its competitors. Mytrex Health Technologies's current Beginning Cash Position is NT$301 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mytrex Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mytrex Health Technologies (ROCO:4431) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$28.73, compared to a current price of NT$19.55 — trading 32% below its estimated fair value. The current Beginning Cash Position is NT$301 Mil. Mytrex Health Technologies' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Mytrex Health Technologies (ROCO:4431), the current Beginning Cash Position is NT$301 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mytrex Health Technologies (ROCO:4431) Overvalued in 2026?

Based on GuruFocus' analysis, Mytrex Health Technologies stock appears to be undervalued. The current stock price of NT$19.55 is trading 32% below its estimated GF Value™ of NT$28.73. GuruFocus considers Mytrex Health Technologies to be Significantly Undervalued.

Key valuation signals for ROCO:4431:

  • Beginning Cash Position: NT$301 Mil
  • GF Value™: NT$28.73 vs. price of NT$19.55 (32% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the ROCO:4431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mytrex Health Technologies Business Description

Address No. 545, Section 2, Hezhen North Road, Zhongli District, Taoyuan, TWN, 32060
Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.
71GF Score

Get the complete analysis for ROCO:4431

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$19.55
Price
NT$28.73
GF Value